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RESEARCH ARTICLE Open Access
Attitudes of Dutch general practitioners
towards vaccinating the elderly: less is
more?
Renske Eilers1,2*, Paul F. M. Krabbe1 and Hester E. de Melker2
Abstract
Background: In many European countries, vaccinations are offered to the elderly. Expanding the programme to
include routine vaccination against pneumococcal disease, herpes zoster, and pertussis, for example, could reduce
disease burden amongst the growing population of persons aged 50 years and older. Since most countries involve
general practitioners (GPs) in the programmes, the potential success of such new vaccinations depends on the
attitude of GPs towards these vaccinations. This qualitative study explores Dutch GPs’ attitudes regarding vaccination in
general, and their attitudes regarding the incorporation of additional vaccines in the current Dutch influenza vaccination
programme.
Methods: Interviews were held with ten Dutch GPs (five men and five women) that worked either in an academic
hospital, in a practice based in a health center, or in individual practice. All interviews were recorded with a digital voice
recorder and transcribed verbatim. Transcripts were analysed according to thematic analysis.
Results: GPs perceived prevention as part as their job and believed vaccination to be effective for preventing infectious
diseases. However, influenza vaccination was not always perceived as effective. Doubts regarding the usefulness of
additional vaccinations were identified. If additional vaccines would be offered, this should be based on scientific
evidence and the severity of the infectious disease. Selection of patients for vaccination should not be based solely on
age, but more on risk factors. The GP should be the central point of contact for new vaccination campaigns; however,
high workload was seen as a concern. Several GPs questioned their ability to refuse to distribute the vaccinations.
Conclusions: A positive attitude towards implementing additional vaccinations is not apparent. Achieving the most
health benefits seems to be the most important consideration of Dutch GPs regarding vaccinating older adults.
Questions regarding the usefulness of vaccinating older adults should be taken into consideration. More research is
necessary to confirm the results among a wider range of Dutch GPs.
Keywords: General practitioners, Vaccine candidates, Interviews, Attitudes, Usefulness of vaccination
Background
Vaccinations are recommended for the elderly in many
European countries. For example, in the Netherlands, a
national influenza vaccination program is offered to per-
sons aged 60 years and older [1]. In other countries,
pneumococcal, diphtheria, tetanus and polio vaccination
are also recommended [2]. There are reasons to expand
these programmes, as demographic change will increase
the elderly population size. In 2007, the Health Council
of the Netherlands indicated that older age groups will
be included in the target population for universal vac-
cination programs [3]. Additional routine vaccination
against, for example, pneumococcal disease, herpes zoster,
and pertussis could reduce the disease burden amongst
those persons aged 50 years and older [4]. Several studies
have indicated that herpes zoster and pneumococcal vac-
cines might be cost-effective for the older adult Western
population [5, 6]. Herpes zoster vaccination is already rec-
ommended for people aged 70, 65, and 50 years and older
in the United Kingdom, France, the Czech Republic and
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Austria, respectively. In Austria, pertussis vaccination is
recommended for people aged 65 years and older [7].
In the Netherlands, the Dutch Ministry of Health,
Welfare and Sport decides which risk groups are to be
invited for the free influenza vaccination program, as
advised by the Health Council of the Netherlands. The
general practitioner’s office is the central point for organ-
izing these immunization campaigns and the general prac-
titioner (GP) (together with the practice nurse) selects,
invites, and vaccinates the target population, accounting
for 95 % of all vaccinations administered to risk groups.
The remaining 5 % of vaccinations are given by others
including a medical officer. Six percent of the target
population had been recommended by a medical spe-
cialist instead of the GP; however, the vaccination itself
was given by the GP [8].
The feasibility of extending current programmes thus
depends on the willingness of the GPs to organize and
endorse these campaigns. From literature on the attitudes
of GPs and healthcare workers (HCWs), it is known that
influenza and pneumococcal vaccinations for the elderly
are considered important and are encouraged [9–12].
Certain concerns have also been reported: the possibil-
ity of negative side effects, low vaccine effectiveness,
and perceived lack of consequences of the disease [13].
In addition, GPs identified their propensity to overlook
vaccination due to their focus on acute medical problems
[14]. They also noted several logistical and educational
barriers, e.g. storage of and information about the vac-
cines [9].
Despite positive attitudes regarding the current vacci-
nations, little is known about GPs’ attitudes regarding
vaccination of older persons in general, or regarding the
potential candidate vaccines for this population. Given
this lack of knowledge, the aim of this qualitative study
was to explore these attitudes among Dutch GPs.
Methods
Selection of participants
Volunteer sampling was used to recruit the GPs. An in-
formation letter was sent to regional societies of general
practitioners which was forwarded to affiliated practices.
Unfortunately, the response rate was low. To include
more GPs, practices across the Netherlands were selected
randomly, taking into account location and type of prac-
tice, and approached directly by letter, followed by a
phone call. If the attending GPs wished to participate,
an appointment was made. In total, ten GPs agreed to
be interviewed. All participants received a gift voucher
following the interview. Informed consent was either
obtained verbally by telephone or in writing by e-mail
by the active enrolment of the GP’s for an interview.
This type of study does not require ethics approval in
the Netherlands because it does not fall under the Med-
ical Research Involving Human Subjects act [15].
Interview
The selected data collecting method was face-to-face in-
terviews. Focus groups were not considered feasible due
to the GPs’ high workload. Interviews were conducted in
May and June 2013 at the general practitioner’s office,
and lasted a maximum of 30 min (as informed before-
hand). All interviews were conducted by the same re-
searcher. Saturation was reached after eight interviews,
meaning that after eight interviews, no new concepts
emerged from the interviews. The conversation was based
on a semi-structured topic list. This topic list was based
on the literature and a focus group study among older
adults in which the role of the GP was discussed. The
open-ended questions covered four topics: 1) the per-
ceived role of the GP concerning prevention in general; 2)
his/her attitude regarding the current influenza vaccin-
ation programme; 3) his/her attitude towards herpes zos-
ter, pneumococcal disease and pertussis, and reasons to
vaccinate (or not) against these diseases; and, 4) the
organization and practicality of vaccinating against add-
itional infectious diseases. The potential candidates for
immunization of persons 50 years and older were herpes
zoster vaccine, pneumococcal vaccine and pertussis vac-
cine. Each interview started with discussion of vaccination
from a broad perspective, and became more vaccination-
specific towards the end. This was achieved by stating that
besides influenza, herpes zoster, pneumococcal disease
and pertussis were also prevalent in elderly persons. No
more information was given. In general, influenza vaccin-
ation was discussed in the beginning of the interview, and
later on the conversation focussed on the potential vaccine
candidates. Following each interview, the GPs were given
the opportunity to indicate if they felt any topics were
missed regarding their attitudes towards the vaccination
of older adults, and to contribute additional information.
However, this was infrequently the case. All interviews
were recorded with a digital voice recorder and tran-
scribed verbatim.
Analysis
The transcripts were analysed with the software program
Nvivo (QSR International) and based on thematic survey
principles [16]. Segments of text were coded by labeling
passages with concepts abstracted from this text. Through
an inductive process, main themes and related subthemes
were identified based on these labelled passages. Themes
were then redefined and reformulated to ensure that the
different themes covered the context of the subthemes. In
total, three rounds of coding were needed.
All interviews were conducted and initially coded by
Renske Eilers (RE); one was coded by an independent
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researcher Irene Harmsen (IH) to minimize researcher
bias. The results were compared, discussed and refined
until consensus on the coding scheme and the labelling
criteria was reached. The coding schemes of RE and IH
were almost identical.
Results
Ten GPs (five women and five men) of various ages (i.e.
it was clear in the face-to-face interviews) were inter-
viewed. All GP’s that were interested in the interview
were interviewed. Unfortunately, no response rate can
be provided because it was not exactly known how many
GPs were notified by the regional GP societies. Three GPs
worked in a general practice within an academic hospital;
three in their own individual practice; and four in a prac-
tice based in a healthcare center. The mean interview time
was 29 min. The nine themes derived from the interviews
are presented below. The GPs’ attitudes regarding these
themes are illustrated by quotes from the interviews.
Prevention and the current influenza vaccination
programme
This first section covers the attitudes on prevention in
general and the current influenza vaccination program
in the Netherlands.
Prevention in general
All ten interviewees agreed that prevention is part of a
GP’s job, concurring that prevention forms an increasing
part of their daily workload. This entails patient educa-
tion and administration of preventive procedures (vaccin-
ation, measuring cholesterol). All GPs felt that vaccination
was a good instrument to prevent infectious diseases. As
one stated: Once more, I believe it to be a very effective,
inexpensive method to prevent lots of trouble and suffering.
(GP 8. Male, Central region of the Netherlands, own
practice).
Attitudes regarding the influenza vaccination programme
Even though GPs believed vaccination to be a good pre-
ventive tool, influenza vaccination was not always con-
sidered effective. Most considered the influenza vaccination
programme useful: I think that the influenza vaccination
programme helps, that it would so to say help to prevent,
well, a massive outbreak. (GP 6, male, Eastern region of the
Netherlands, own practice) Others did not: Personally, I
have the impression that the influenza vaccinations have no
effect whatsoever, but of course that is not science, but that
is not the impression of the people who get the shot, they
manage to get through the winter better, so to say, they get
through their year better. (GP 7, male, Central region of the
Netherlands, own practice) And even some who were posi-
tively inclined towards vaccination had reservations about
lowering the age limit to 60 years, as was done in 2008 in
the Netherlands: But I do wonder about one thing, should it
already be offered to people over 60, of course it used to be
65 (…) continues: We are all growing steadily older and we
are, let’s say, relatively young for a longer time, so I find that
a hard one to judge. (GP 4, female, Central region of the
Netherlands, practice in healthcare center).
Potential vaccine candidates and the expansion of the
influenza vaccination programme
Usefulness
In general, the idea of vaccinating older adults against
additional infectious diseases was not well received. The
majority of the GPs thought that availability in itself did
not justify distributing the vaccine. Because they felt that
experiencing disease is part of life, vaccination was not
deemed a precondition for healthy ageing: (…) yes, there
is a tendency to try to avoid all of life’s risks and I can’t
help but think that that is not how life is. (GP 1, female,
Northern region of the Netherlands, practice in academic
hospital). They saw life as finite and death as a redeemer.
As one GP said: Once again, those who die of it [the flu]
will be the weaker brothers and sisters, who are already
confined to bed, or suffer from Parkinson’s or a serious case
of COPD, or whatever. And then the end is actually merci-
ful. (GP 7, male, Central region of the Netherlands, own
practice) Pneumococcal disease was also given as an ex-
ample, calling it an old man’s best friend: Oh, well no, I
mean if you are 85 and your life isn’t rosy, or you have
really had enough, pneumococcal disease, pneumonia,
can be a kind way to depart. (GP 9, female, Central re-
gion of the Netherlands, practice in healthcare center).
Expanding the range of vaccines in the programme
could also have negative consequences on the perceived
severity of a disease, as one GP mentioned: Yes, and I
also think, like from the moment that you offer vaccina-
tions for shingles that – oh, so shingles is apparently a
serious illness. What I mean to say is that people’s per-
ception will change. (GP 8, male, Central region of the
Netherlands, own practice).
An epidemic is one situation for which adding vaccines
to the programme could be justified. And some GPs saw
the provision of additional vaccines as an advance in
medicine, for obtaining health and healthy ageing.
Considerations regarding potential vaccines
Two main arguments were identified for the way GPs
expressed their willingness to consider potential new vac-
cines. These are ‘evidence-based practice’ and ‘severity of
the infectious disease’.
Evidence-based practice
Evidence-based practice was considered very important,
especially regarding a vaccine’s effectiveness and side-
effects. Good vaccine characteristics formed a condition
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for implementing a new vaccine. As one GP explained:
You have to be sure it is useful, you have to be sure it
helps, that it has no negative effects and that you can
really prevent problems. (GP 5, male, Southern region of
the Netherlands, practice in healthcare center) Two
others wondered whether vaccination could still benefit
older adults, questioning how effective the immune re-
sponse would be in an ageing immune system. If the
vaccine could not prevent disease, it should at least re-
duce the disease burden. GPs discussed the balance be-
tween side-effects and vaccine effectiveness: If there are
a lot of mild or some serious side-effects, while the ef-
fectiveness is maybe not all that high, then I think, yeah,
then you should not do this. The overall effect should be
balanced. (GP 3, male, Northern region of the Netherlands,
practice in academic hospital) Although side-effects are
no reason to advise against vaccination, they should be
taken into account: But I think that whatever you do,
whatever interventions you make, you should also give
due consideration to what the other side of it is, the
side-effects, so the same goes for vaccinations. (GP1, fe-
male, Northern region of the Netherlands, practice in
academic hospital) If new vaccines were to be intro-
duced, GPs assumed that implementation rested on
thorough scientific evidence. As one GP stated: Yes,
certainly. But I just assume that that has been deter-
mined before it will even have been considered as an
addition to the vaccination programme (…) Continues:
The studies checking whether or not it is safe, I’ll take
those for granted. (GP 4, female, Central region of the
Netherlands, practice in healthcare center) This as-
sumption also applied to their role in informing pa-
tients: Well, that is very important to me, I do want to
be able to give a good, justified explanation to my pa-
tients that it is useful to do it, just like I would do with
any medical interventions. (GP2, female Northern re-
gion of the Netherlands, practice in academic hospital)
Finally, to some GPs cost-effectiveness was an import-
ant aspect of evidence-based practice: Right, and it
should not be an afterthought that you have to consider
the costs and benefits. We happen to live in times when
we have to be frugal with every euro we spend. (GP5,
male, Southern region of the Netherlands, practice in
healthcare center).
Severity of the infectious disease
The second important argument is the severity of dis-
ease. Although the initial disease burden of herpes zoster
was perceived to be quite low, its consequences could be
severe, justifying vaccination: Essentially, the number of
complaints that people have while they are suffering from
that seems to be reasonable, as far as I can tell, but what
counts is the number of complaints afterwards. (GP 3,
male, Northern region of the Netherlands, practice in
academic hospital) Pneumococcal disease was consid-
ered severe enough to warrant vaccination due to its
mortality rate.
Although pertussis was not perceived as severe enough
among the elderly to justify vaccination, it was perceived
as a threat to infants. In that light, ensuring herd immun-
ity to protect children was considered a benefit of per-
tussis vaccination among the elderly. Take pertussis, for
instance, you do it above all to protect infants, to make
sure that infants cannot get infected. (GP 5, male,
Southern region of the Netherlands, practice in health-
care center) The frequency of GPs encountering patients
with a clinical syndrome during consultations appears to
influence the GP’s perception of its severity. GPs were not
often consulted for the three infectious diseases discussed
here; herpes zoster was the one they saw most.
Practical implications and implementation
GPs contemplated the practicalities of offering additional
vaccines to older adults. In particular, they discussed the
practicalities of adding new vaccines to the current influ-
enza vaccination programme. They raised issues about
the target population, the participating organizations,
possible barriers, and autonomy.
Target population
The GPs felt that deciding who should receive the vaccin-
ation should not be based solely on age. Their reservations
reflected the perceived lack of health benefits: And again,
that is the point, what do we gain by vaccinating the entire
elderly population? (GP 2, female, Northern region of the
Netherlands, practice in academic hospital) It would be
preferable to select people for vaccination on the basis
of criteria such as co-morbidities to identify a high-risk
population: Of course, the benefit of the influenza vacci-
nations is the prevention of complications in vulnerable
persons. And then if you start giving it to everyone –
well, if you and I get the flu, then it’s a nuisance, but
you get over it. So there is no real need for a vaccination.
(GP 5, male, Southern region of the Netherlands, practice
in healthcare center).
Participating organizations
All interviewees agreed that the GP’s office should be
the central point for new vaccination campaigns. They
dismissed the idea of leaving it up to other organizations
such as the Public Health Service. As one GP stated:
Well that was clear then, at the time of that Mexican
flu, that there was no organization, that is, apart from
the GP’s office, that was able to carry out such a mass
vaccination campaign in a very short time. So I think
that should we do the preventive vaccinations, that the
GP practice is the most suitable of all organizations, that
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is where it should be. (GP 5, male, Southern region of the
Netherlands, practice in healthcare center).
In addition, GPs felt that vaccinations should be given
by a single organization: I think it would be silly, going to
your GP for your flu shot, but to the GGD [Public Health
Service] for a vaccination for pneumococcal disease. (GP
10, female, Central region of the Netherlands, practice in
healthcare center) The latter respondent stated that even
though the amount of work might triple by offering
more vaccines, the GP should still be the preferred
provider.
Two arguments were identified for this statement. First,
using the GP’s practice ensures high coverage because
GPs can effectively reach the target population. This is
enhanced by the long-lasting patient-doctor relation-
ship and the perceived prestige of GPs in the eyes of
older adults that creates trust. The current influenza
vaccination programme was taken as an example: But
well, I believe we can deliver that message – like hey, it’s
useful, just do it, yes – better, I think, than anyone else
in primary care, than the district health team. In gen-
eral, we will have been in touch with the elderly for
years, have treated them for years, so yes, alright, that
implies we have built up trust, and that makes it rather
easy to advise them, or means, for instance, that such
advice will be taken. And that is what you see happen
with the influenza vaccination. (GP 8, male, Central re-
gion of the Netherlands, own practice). The second ar-
gument is more practical. If a vaccination programme
is based on for example co-morbidity criteria (as preferred
by the GPs), that selection process would necessarily in-
volve the GPs: It would not be very smart of the authorities
if they would not involve the GP (…) continues; As far as
I’m concerned, there is no other organization that knows
the people as well as the GP. He is aware if the indications,
has an exact registration of the medical history, and for
the time being there is no other organization that can
implement it. (GP 5, male, Southern region of the
Netherlands, practice in healthcare center).
Another role that the GPs identified for themselves is
as the role of an advisor in their patients’ decision-
making: I’ll give advice, I won’t tell them what to do. No.
(GP 4, female, Central region of the Netherlands, practice
in healthcare center). The role of the GP depends on the
individual patient: Well, that is really just about what
you do as a doctor and what the patient likes to see and
get. And by now, I do know my elderly patients, and
some, well they like to discuss things and then you go
along, and others expect to get more directions, and then
you tell them what they should do. (GP 3, male, Northern
region of the Netherlands, practice in academic hospital).
Even if another organization were to be involved, GPs
felt that they should have an important informative role
to play because people would turn to them with their
questions: Well, I think that in that respect, seeing that all
those people come to us to ask about it, that the patients
think it is important what our opinion is. So in that re-
spect, we have an important role in informing them (GP3
male, Northern region of the Netherlands, practice in aca-
demic hospital).
Potential barriers
One potential barrier for adding additional vaccinations
was the extra workload. Some GPs remarked that organ-
izing the influenza vaccination programme alone is an
extensive undertaking: It does have a big impact, we have
an influenza committee here, that starts up early on, all
those people have to be selected. The GPs have to be chased
to assess all those people. Altogether, it is a lot of bother.
(GP 3, male, Northern region of the Netherlands, practice
in academic hospital). However, not all GPs felt that the
extra workload would be insurmountable if financial com-
pensation was forthcoming. As one GP stated: Yes, bar-
riers can be overcome in principle, but these tasks have to
be facilitated, our professional group is naturally given
quite a lot of tasks. (GP 1, female, Northern region of the
Netherlands, practice in academic hospital). Others, in
contrast, believed that handling the distribution of the in-
fluenza vaccine would be easy, indicating that implemen-
tation of additional vaccines would not be a problem: But
really, that influenza programme, that runs very smoothly,
it’s easy to carry it out, it is only one shot. So it takes two
or three hours, really, per year, so it does not take much
time. (GP 6, male, Eastern region of the Netherlands, own
practice).
Vaccine-specific selection criteria would add to the
workload. To keep it within bounds, GPs would opt for
similar selection criteria and combination vaccines. There-
fore, they preferred any additional vaccines to be imple-
mented within the influenza vaccination programme: If
the criteria would be the same that would make it a lot
easier, and of course it would be best if they would both be
simultaneous, like in both arms or as a cocktail vaccine
like with hepatitis A and B. That would be handy, from a
logistic point of view. (GP 3, male, Northern region of the
Netherlands, practice in academic hospital) Another GP
put it succinctly: I simply want to be able to order the right
numbers on let’s say, the same website, that everything
is just the same. (GP 4, female, Central region of the
Netherlands, practice in healthcare center) At the same
time, the GPs foresaw restrictions on the patients’ freedom
to choose a particular vaccine: Well, see, assume that you
could give it as one shot, then that would be easier, it
would be less work, but then there might be people who say
they want the one shot but not the other. I could imagine
that that would complicate things. (GP 9, female, Central
region of the Netherlands, practice in healthcare center).
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Autonomy
Several GPs questioned their ability to refuse to distrib-
ute the vaccinations, indicating that a positive attitude is
not always necessary. They don’t believe that they have
the authority to decide whether to vaccinate or not: Well
like that influenza vaccination, I am happy to leave that
up to the authorities who in their wisdom have decided
to adopt that programme – oh well, then I’ll just go along
with it, I’m just an employee, so to speak. (GP 7, male,
Western region of the Netherlands, own practice) Others
did feel autonomous with respect to their own conditions:
If it is being offered, then it has been decided that it is
worth it. Then I’ll just go along with it. But obviously, the
costs should somehow be proportional to the benefits, the
number of people that benefit from it, the disease burden.
(GP 9, female, Central region of the Netherlands, practice
in healthcare center).
Discussion
This qualitative study offers insight into the attitudes of
Dutch GPs regarding the vaccination of older adults and
regarding potential new vaccines candidates. Nine themes
that reflect the attitudes of Dutch GPs were identified:
prevention and the influenza vaccination programme;
usefulness of additional vaccines; evidence-based practice;
severity of the infectious disease; target population; par-
ticipating organizations; potential barriers; and autonomy.
A positive attitude towards prevention in general and
vaccination in particular does not necessarily imply a
positive attitude regarding additional vaccinations. The
interviews revealed several reasons why the GPs doubted
the usefulness of potential vaccine candidates. First, they
questioned eligibility for vaccination based solely on age
criteria. Selection based on co-morbidity was considered
more useful. Furthermore, they were concerned that
implementation of a vaccine might cause the elderly to
perceive certain infectious diseases as more serious. Ac-
cording to the interviewed GPs, the initial clinical syn-
dromes of both herpes zoster and pertussis are not
perceived as severe enough to warrant vaccination. Fi-
nally, they felt that it was not right to avoid all risks in
life, not even the risk of death. In this light, pneumonia
was seen as the old man’s best friend. The addition of
other vaccinations to the influenza vaccination program
may therefore involve ethical issues/challenges such as
ageism (which is referred to as stereotyping or discrim-
inating based on age), because implementation will
most likely be age-dependent, and the ethics surround-
ing end-of-life decisions.
The influenza vaccination programme was initiated in
1997 and has since become common practice in the
Netherlands [1]. Not all GPs had a positive attitude to-
wards this vaccination programme. Nonetheless, distri-
bution of the vaccine has become a routine part of their
job. This ambivalence may emanate from their perception
of themselves as not fully autonomous in the decision to
give vaccinations. GPs comply with decisions made by the
government, trusting that sufficient evidence has been
gathered to justify the implementation of a new vaccine.
Some GPs stated that certain conditions should be met,
especially re-imbursement, to facilitate the distribution of
the vaccines by the GPs.
Despite their ambivalent attitudes, they felt that if
additional vaccines were introduced, GPs should be in-
volved, regardless of their lack of a positive attitude or
their high workload. Their role would be that of a consult-
ant or advisor to the patients and/or as the organizer of
the vaccination campaigns. In addition, they considered
the GP office to be the most suitable place for distribution
because it forms the locus of the patient-doctor trust
relationship and the selection of patients eligible for
vaccination.
Previous studies suggested that the GP plays an import-
ant role in the vaccination decision-making process of an
older person [17]. GPs might play a key role in ensuring a
high uptake of current and future vaccines. To this end,
the support of the GPs should be optimized. This study
suggests that their support could be won by providing
them with appropriate information, given the importance
they ascribe to evidence-based practice. Supply of infor-
mation would also encourage a more positive attitude to-
wards vaccination. That, in turn, would facilitate patient
education and assist GPs in caring out their advisory role
in the decision-making process of the elderly.
Qualitative studies on GPs’ attitudes towards (new) vac-
cines are scarce. Those that have been published focus on
existing programmes and vaccination rates [18]. Accord-
ing to Swiss GPs, although pneumococcal disease was per-
ceived as potentially severe, pneumococcal vaccination
was found to be the least important vaccination in their
daily practice, especially compared to influenza vaccin-
ation [18]. In our study, however, pneumococcal disease
was identified as the most likely potential vaccine candi-
date when considering the attitude of the interviewed GPs
[18]. Other studies have emphasized the importance of
good vaccine characteristics [13, 19, 20], the disease bur-
den caused by herpes zoster, specifically the longer-term
consequences [20], the disease burden caused by pneumo-
coccal disease [21], and the importance of vaccination as a
preventive tool [22]. The literature on pneumococcal vac-
cination indicates that target population vaccination is
preferred above general population vaccination based on a
single age criterion [12, 13, 21, 23]. This conclusion is also
drawn here.
Interestingly, the GPs interviewed in the present study
questioned the usefulness of expanded immunization
programmes for older adults. In the literature, this issue
has only been addressed briefly by Van Haaren and not
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in other studies referenced within this article. The GPs
interviewed in this study indicated that healthy elderly
persons could withstand the flu, thus arguing against
vaccinating the elderly against influenza [23].
Study strengths and limitations
Given the low response rate, and consequently the low
number of interviewed GPs, the present study was prone
to selection bias. GPs have a high workload, and those
GPs who were willing to participate might have had a
strong interest in research or in elderly vaccination, or
may have been critical of the topic. Also, GPs working
an academic hospital were probably over-represented.
Therefore questions might be raised concerning the rep-
resentativeness of the study population. However, even
though only 10 GPs were interviewed, they were located
across the Netherlands, and saturation of the data was
present after eight interviews. It is thus likely that the
survey gathered all points of view. Nonetheless, the vari-
ous attitudes identified in this study should be quantified.
Conclusions
This qualitative study suggests that GPs do not necessar-
ily have a positive attitude regarding the addition of po-
tential vaccine candidates to the current Dutch influenza
vaccination programme. The main challenge to expanding
the vaccination programme to include potential vaccine
candidates within the influenza vaccination schedule is
how to achieve the most health benefits. Some questions
about the usefulness of vaccinating remain unanswered.
Thus, the degree of support among GPs, who are key
players in the vaccination decision-making process of the
elderly, is not yet clear. Further studies are needed to
quantify the observations presented in this qualitative
study, and to extend the research to encompass a larger
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